AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...
STAT9h
Lawmakers ask FDA to review Hims’ Super Bowl ad for ‘misleading’ patients
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...
FoodNavigator-Asia21h
Safety First: South Korea food labels, Indonesia GM hoaxes, China safety concerns and more
South Korea food labels, Indonesia GM food hoaxes, China food safety concerns and more feature in this edition of Safety First.
STAT1d
FDA clinical trial inclusivity guidelines will be back
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
Azorobotics1d
AI Prediction System for Idiopathic Multicentric Castleman's Disease
Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering ...
Camden News1d
U.S. food, drug makers have 2 to 3 years to remove banned Red No. 3 from products
The Food and Drug Administration has revoked use of the synthetic dye Red No. 3 -- approved to provide color in food and ...
News Medical1d
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Nutrition labels meant to promote healthy eating could discourage purchases
Some food labels designed to nudge Americans toward healthier food choices can have the opposite effect, new University of ...
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent
Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing an ...
Global Peptide-Drug Conjugate Market To Show Enormous Growth At A CAGR Of ~29% By 2032 Delveinsight
The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effect ...
Experts: Journavx a prescription to stem Long Island's addiction crisis
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...